tiprankstipranks
UpHealth (UPHL)
OTHER OTC:UPHL

UpHealth (UPHL) Income Statement

338 Followers

UpHealth Income Statement

Last quarter (Q4 2023), UpHealth's total revenue was $17.35M, a decrease of -55.13% from the same quarter last year. In Q4, UpHealth's net income was $-10.02M. See UpHealth’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 126.61M$ 130.00M$ 110.95M$ 123.80M$ 5.40M
Cost of Revenue
$ 25.88M$ 60.40M--$ 1.18M
Gross Profit
$ 65.93M$ 69.59M$ 70.16M$ 43.59M$ 4.21M
Operating Expense
$ 41.39M$ 159.17M$ 231.55M$ -423.57M$ 6.14M
Operating Income
$ -79.53M$ -89.57M$ 63.60M$ -44.84M$ -1.93M
Net Non Operating Interest Income Expense
$ -27.61M$ -28.20M$ -26.38M$ -19.03M$ -130.00K
Other Income Expense
$ -12.28M$ -60.13M$ 66.84M$ -18.47M$ 4.00K
Pretax Income
$ -56.32M$ -57.63M$ -232.32M$ -342.77M$ -2.06M
Tax Provision
$ 7.14M$ -1.22M$ -9.38M$ -2.44M$ 50.00K
Earnings From Equity Interest Net Of Tax
---$ -561.00K$ -80.00K
Net Income Common Stockholders
$ -64.59M$ -57.84M$ -223.00M$ -341.02M$ -2.19M
Basic EPS
$ -5.89$ -3.26$ -15.17$ -3.19$ -0.02
Diluted EPS
$ -5.89$ -3.26$ -15.17$ -3.19$ -0.02
Basic Average Shares
$ 67.17M$ 17.72M$ 14.70M$ 107.03M$ 117.60M
Diluted Average Shares
$ 67.17M$ 17.72M$ 14.70M$ 107.03M$ 117.60M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 67.27M$ 219.57M$ 231.55M$ -423.57M$ 7.32M
Net Income From Continuing And Discontinued Operation
$ -64.59M$ -57.84M$ -223.00M$ -341.02M$ -2.19M
Normalized Income
$ -18.76M$ -27.69M--$ -2.19M
Interest Expense
----$ 134.00K
EBIT
$ -28.73M$ -29.44M$ -205.82M$ -333.06M$ -1.92M
EBITDA
$ -9.08M$ -6.05M$ -167.20M$ -307.41M$ -1.60M
Currency in USD

UpHealth Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis